| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |